Travere Therapeutics, Inc., a biopharmaceutical company, has confirmed that an incident occurred which may have compromised personal information. On October 27, 2025, the company filed notice regarding this data security event, alerting affected individuals in New Hampshire.
While the specific nature of the event is not yet fully detailed, it is understood that the information involved could include various pieces of your personal data. Notifications are being sent to those whose information may have been exposed as a result of this breach.
If you received a data breach notification letter from Travere Therapeutics, Inc., it indicates that your personal information was potentially accessed by unauthorized parties. This type of incident can create risks for identity theft, fraud, and other forms of misuse of your data.
To help protect yourself, it is advisable to remain vigilant. Carefully review any account statements or financial records for unusual activity, and be cautious of unsolicited communications that ask for personal details. Consider placing a fraud alert or credit freeze with credit bureaus.
Attorneys are investigating this data breach on behalf of those affected. If a class action lawsuit is pursued, it would aim to hold Travere Therapeutics, Inc. accountable and potentially recover damages for the harms caused by the exposure of personal information. This investigation is in its early stages.
Individuals who received a notification letter about the Travere Therapeutics, Inc. data breach may be entitled to legal recourse. Understanding your rights and potential options is crucial in the aftermath of such an event.